Clinical Trial Update: Bay98-7196, Dose Finding / POC Study [Phase 2]

View source ↗

Summary

Phase 2 dose-finding/poc study of Bay98-7196 for endometriosis has completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Bay98-7196

Snippet

Sponsor: Bayer | Conditions: Endometriosis | Phase 2 | Status: COMPLETED | Results posted: 2018-01-04